Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 27 Neoplasm Metastasis 8 Colonic Neoplasms 7 Rectal Neoplasms 5 Pancreatic Neoplasms 4 Stomach Neoplasms 3 Neoplasms 3 Carcinoma, Neuroendocrine 2 Pancreatic Adenocarcinoma Metastatic 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Metastatic Colorectal Adenocarcinoma 1 Margins of Excision 1 Liver Metastasis Colon Cancer 1 Gastroesophageal Adenocarcinoma 1 CRC 1 Advanced Gastric or EGJ Cancer 1 Adenocarcinoma 1

Interventions

Microscopy, Confocal 2 Indocyanine Green 2 Ultrasonography 1 Tumor Burden 1 Sunitinib 1 Simvastatin 1 Radiosurgery 1 Palliative Care 1 Observation 1 Neoadjuvant Therapy 1 Narrow Band Imaging 1 Mastectomy, Segmental 1 IFL protocol 1 Gastrectomy 1 Folfox protocol 1 Everolimus 1 Esophagectomy 1 Endoscopic Mucosal Resection 1 Drug Delivery Systems 1 Drug Combinations 1 Dermoscopy 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Margins of Excision × IFL protocol × Clear all

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡